CG Oncology, Inc. Common stock
CGON
$62.62-0.81%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$4.74B
EV/Sales
1165.5
P/E ratio
N/A
FY2025 Revenue
$4.04M
EPS (TTM)
$-2.69
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-3985.02%
Beta
0.31
Div yield
N/A
Sector
Healthcare
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Use this CGON research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CGON income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
CG Oncology, Inc. Common stock (CGON) is a biotechnology company in the Healthcare sector.
Latest cached CG Oncology, Inc. Common stock (CGON) revenue for Dec 31, 2025 was $4.0M. Net income was -$161.0M. Statements: https://lician.com/financials/cgon
CG Oncology, Inc. Common stock (CGON) market capitalization is $4.74B on the latest cached snapshot.
CG Oncology, Inc. Common stock (CGON) cached previous close $63.13; day range $61.92 – $62.62; volume 353,583. Session quote: https://lician.com/quote/cgon
CG Oncology, Inc. Common stock (CGON) latest cached earnings event is "CGON earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CGON filing is 8-K · Aug 6, 2026. Filings: https://lician.com/sec/cgon